BIOMAT Database Logo BIOMAT Database Logo

Transcatheter arterial chemo-embolization for humoral hypercalcemia of hepatocellular carcinoma. 1988

K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
Second Department of Internal Medicine, Osaka University Medical School, Japan.

A 50-year-old male with unresectable hepatocellular carcinoma (HCC) had a hypercalcemic crisis with a serum calcium concentration of 7.8 mEq/zeta, without any evidence for bone metastases or parathyroid lesions. The hypercalcemia was thought to be due to increased renal reabsorption of calcium and increased bone resorption, which was probably caused by humoral factors derived from the HCC, some being parathyroid hormone-like factors. Since conservative therapy for hypercalcemia was not sufficiently effective and was accompanied by progressive exacerbation of ascites and leg edema, transcatheter arterial chemo-embolization (TACE) was performed. On the following day, serum calcium concentration decreased from 6.3 mEq/zeta to the normal range, although serum alpha-fetoprotein levels decreased only slightly. Thereafter hypercalcemia did not develop for about 4 weeks. The results demonstrated that TACE can be effective for humoral hypercalcemia of HCC.

UI MeSH Term Description Entries
D007459 Iodized Oil A preparation of oil that contains covalently bound IODINE. It is commonly used as a RADIOCONTRAST AGENT and as a suspension medium for CHEMOTHERAPEUTIC AGENTS. Oil, Iodized,Iodized Oils,Iodolipol,Oils, Iodized
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali

Related Publications

K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
[Pathomorphological study of resected hepatocellular carcinoma after transcatheter hepatic arterial chemo-embolization].
February 1993, Zhonghua bing li xue za zhi = Chinese journal of pathology,
K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
Gastroduodenal lesions after transcatheter arterial chemo-embolization in patients with hepatocellular carcinoma.
August 1988, The American journal of gastroenterology,
K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
[Histopathologic study on resected hepatocellular carcinoma after transcatheter hepatic arterial chemo-embolization].
July 1991, Zhonghua yi xue za zhi,
K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
The CT evaluation of transcatheter arterial chemo-embolization, using iodized oil for hepatocellular carcinoma.
March 1990, Medical journal of Osaka University,
K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
[Hepatocellular carcinoma: treatment with arterial chemo-embolization].
May 1994, Presse medicale (Paris, France : 1983),
K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
Transcatheter chemo-embolization for hepatocellular carcinoma and certain hepatic metastasis.
March 2004, JPMA. The Journal of the Pakistan Medical Association,
K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
Histopathology of portal tracts in livers after transcatheter arterial chemo-embolization therapy for hepatocellular carcinoma.
January 1994, Journal of gastroenterology and hepatology,
K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
Hepatic arterial embolization for malignant hypercalcemia in hepatocellular carcinoma.
May 1984, Digestive diseases and sciences,
K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
Segmental transcatheter arterial embolization for primary hepatocellular carcinoma.
December 1998, World journal of gastroenterology,
K Suzuki, and N Kono, and A Ono, and Y Osuga, and H Kiyokawa, and I Mineo, and Y Matsuda, and S Miyoshi, and S Kawata, and Y Minami
Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma.
January 2002, Hepato-gastroenterology,
Copied contents to your clipboard!